Biosergen AB (OSTO:BIOSGN) Preferred Dividends : kr0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Biosergen AB's preferred dividends for the three months ended in Mar. 2025 was kr0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.00 Mil.

Biosergen AB Preferred Dividends Historical Data

The historical data trend for Biosergen AB's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosergen AB Preferred Dividends Chart

Biosergen AB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Preferred Dividends

Biosergen AB Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Preferred Dividends	Get a 7-Day Free Trial													-	-	-	-	-

Biosergen AB Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Biosergen AB (OSTO:BIOSGN) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

Biosergen AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (OSTO:BIOSGN) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fogdevreten 2, Solna, SWE, 17165

Website

https://www.biosergen.net

Biosergen AB is a clinical stage biotechnology company advancing the treatment of life-threatening fungal infections. Biosergen' s mission is to develop the drug candidate BSG005 into a superior antifungal therapy with broader efficacy and improved safety over existing treatments. BSG005 potential is to eliminate fungal infections rather than just slowing their growth, reducing the risk of resistance.

Biosergen AB Headlines

No Headlines